Literature DB >> 21641100

[Changing epidemiology of native valve infective endocarditis].

Juan C Castillo1, Manuel P Anguita, Martín Ruiz, Luisa Peña, Marta Santisteban, Miguel Puentes, José M Arizón, José Suárez de Lezo.   

Abstract

INTRODUCTION AND
OBJECTIVES: The aim of our study is to assess changes in the epidemiologic features of patients with native valve infective endocarditis.
METHODS: We analyzed a prospective series of 228 cases of native valve infective endocarditis in non-intravenous drug users attending our center between 1987 and 2009. We compared three subperiods: 1987-1994 (67 cases), 1995-2002 (74 cases) and 2003-2009 (87 cases).
RESULTS: The mean age of patients has progressively increased (38±22 years in the first subperiod vs 60±16 years in the third; P<.001), as has the proportion of cases without predisposing heart disease (25%, 46% and 67%; P<.001). Incidence of mitral valve prolapse remained stable (12%, 18% and 11%). Percentages of patients with predisposing heart disease and who were aware of their condition have fallen in recent years (45%, 27% and 21%; P<.001). A portal of entry for the infection could not be identified in 64%. Overall, Staphylococcus aureus is the most frequent causative organism (26%) whereas the percentage of cases caused by Streptococcus viridans remains unaltered (22%, 20% and 24%).
CONCLUSIONS: We found significant changes in the epidemiology of native valve infective endocarditis. The incidence of patients without predisposing heart disease has increased significantly and staphylococci are the most frequent causative organisms. Full English text available from: www.revespcardiol.org.
Copyright © 2011 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21641100     DOI: 10.1016/j.recesp.2011.03.011

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  7 in total

1.  Native aortic valve fungal endocarditis.

Authors:  Shyam Chand Chaudhary; Kamal Kumar Sawlani; Rahul Arora; Vivek Kumar
Journal:  BMJ Case Rep       Date:  2013-02-20

2.  A Study of Clinical, Microbiological, and Echocardiographic Profile of Patients of Infective Endocarditis.

Authors:  Soumik Ghosh; Ratnakar Sahoo; Ranjit Kumar Nath; Nandini Duggal; Adesh Kumar Gadpayle
Journal:  Int Sch Res Notices       Date:  2014-11-04

3.  Risk factors for poor prognosis in nosocomial infective endocarditis.

Authors:  Ji-Won Hwang; Seung Woo Park; Eun Jeong Cho; Ga Yeon Lee; Eun Kyoung Kim; Sung-A Chang; Sung-Ji Park; Sang-Chol Lee; Cheol-In Kang; Doo Ryeon Chung; Kyong Ran Peck; Jae-Hoon Song
Journal:  Korean J Intern Med       Date:  2017-06-02       Impact factor: 2.884

4.  The changing epidemiology and clinical features of infective endocarditis: A retrospective study of 196 episodes in a teaching hospital in China.

Authors:  Wan Zhu; Qian Zhang; Jingping Zhang
Journal:  BMC Cardiovasc Disord       Date:  2017-05-08       Impact factor: 2.298

5.  Clinical characteristics, microbiology, and outcomes of infective endocarditis in Qatar.

Authors:  Ahmed Zaqout; Shaban Mohammed; Maliha Thapur; Hussam Al-Soub; Muna A Al-Maslamani; Abdullatif Al-Khal; Ali S Omrani
Journal:  Qatar Med J       Date:  2020-09-28

6.  Clinical Features and Outcome of Infective Endocarditis in a University Hospital in Romania.

Authors:  Emilia Elena Babeș; Diana Anca Lucuța; Codruța Diana Petcheși; Andreea Atena Zaha; Cristian Ilyes; Alexandru Daniel Jurca; Cosmin Mihai Vesa; Dana Carmen Zaha; Vlad Victor Babeș
Journal:  Medicina (Kaunas)       Date:  2021-02-10       Impact factor: 2.430

7.  Symptomatic peripheral mycotic aneurysms due to infective endocarditis: a contemporary profile.

Authors:  Isabel González; Cristina Sarriá; Javier López; Isidre Vilacosta; Alberto San Román; Carmen Olmos; Carmen Sáez; Ana Revilla; Miguel Hernández; Jose Luis Caniego; Cristina Fernández
Journal:  Medicine (Baltimore)       Date:  2014-01       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.